Femasys Inc. (FEMY) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on August 10, 2023, by Femasys Inc., a Delaware corporation and emerging growth company. The filing primarily serves to announce the Company's financial results for the second quarter ended June 30, 2023, and to disclose a significant executive appointment.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) containing the specific financial results for the second quarter ended June 30, 2023. However, the body of this 8-K does not explicitly state numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these specific figures.
Material Changes and Executive Updates
The most significant material change disclosed in this filing is the appointment of Daniel Currie as Chief Operating Officer (COO), effective August 10, 2023. Mr. Currie previously served as Senior Vice President, Operations since 2009. He brings over 30 years of experience in the medical device industry, including roles at CIBA Vision Corporation and Novoste Corporation.
Compensation and Management Commentary
As part of his new role as COO, Mr. Currie will receive an annual base salary of $389,000, retroactive to January 1, 2023. He is also eligible for a target bonus of 40% of his annual base salary contingent on the achievement of corporate goals. Additionally, he will continue to participate in the Company's equity incentive plan consistent with practices for senior executives.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2023 revenue, net income, and cash flow figures not detailed in the 8-K text.
- Verify the impact of the new COO appointment on operational strategy and cost structure.
- Confirm the retroactive salary adjustment details and its impact on the Company's compensation expense for the fiscal year.
- Check for any forward-looking guidance or updated financial outlook provided in the referenced press release.